HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tissue carnitine homeostasis in very-long-chain acyl-CoA dehydrogenase-deficient mice.

Abstract
Deficiency of very-long-chain acyl-CoA dehydrogenase (VLCAD) is the most common long-chain fatty acid oxidation defect and presents with heterogeneous clinical manifestations. Accumulation of long-chain acylcarnitines and deficiency of free carnitine have often been proposed to play an important role in disease pathogenesis. The VLCAD-deficient mouse exhibits similar clinical and biochemical phenotypes to those observed in humans and, therefore, represents an excellent model to study VLCAD deficiency. We measured carnitine and acylcarnitine profiles in liver, skeletal muscle (SkM), bile, and blood from VLCAD knock-out mice and controls under nonstressed and various stress conditions. Carnitine and acylcarnitines were extracted from body fluids with methanol and from tissues with acetonitrile, respectively, and were analyzed as their butyl esters using electrospray ionization tandem mass spectrometry. Fasting combined with a cold challenge for 8 h significantly induced liver long-chain acylcarnitine and free carnitine production. Acylcarnitines in SkM predominantly accumulated during exercise with a concomitant decrease of free carnitine. Changes in blood free carnitine did not correlate with carnitine homeostasis in liver and SkM. Our results demonstrate different tissue-specific long-chain acylcarnitine profiles in response to various stressors, which may be of importance with respect to the heterogeneous clinical manifestations of VLCAD deficiency in humans. Furthermore, we conclude that carnitine biosynthesis in the liver seems sufficiently active to maintain liver carnitine levels during increased demand. Our data suggest that carnitine supplementation in long-chain beta-oxidation defects may not be required, and blood carnitine concentrations do not reflect tissue carnitine homeostasis.
AuthorsUte Spiekerkoetter, Chonan Tokunaga, Udo Wendel, Ertan Mayatepek, Lodewijk Ijlst, Frederic M Vaz, Naomi van Vlies, Henk Overmars, Marinus Duran, Frits A Wijburg, Ronald J Wanders, Arnold W Strauss
JournalPediatric research (Pediatr Res) Vol. 57 Issue 6 Pg. 760-4 (Jun 2005) ISSN: 0031-3998 [Print] United States
PMID15774826 (Publication Type: Journal Article)
Chemical References
  • acylcarnitine
  • Acyl-CoA Dehydrogenase, Long-Chain
  • Carnitine
Topics
  • Acyl-CoA Dehydrogenase, Long-Chain (deficiency, genetics)
  • Animals
  • Bile (metabolism)
  • Carnitine (administration & dosage, analogs & derivatives, blood, metabolism)
  • Disease Models, Animal
  • Homeostasis
  • Humans
  • Lipid Metabolism, Inborn Errors (blood, drug therapy, genetics, metabolism)
  • Liver (metabolism)
  • Mice
  • Mice, Knockout
  • Muscle, Skeletal (metabolism)
  • Phenotype

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: